Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutations.
BACKGROUND: The success of antiretroviral therapy is known to be compromised by drug-resistant HIV-1 at frequencies detectable by conventional bulk sequencing. Currently, there is a need to assess the clinical consequences of low-frequency drug resistant variants occurring below the detection limit...
Main Authors: | Jeffrey A Johnson, Jin-Fen Li, Xierong Wei, Jonathan Lipscomb, Diane Bennett, Ashley Brant, Mian-Er Cong, Thomas Spira, Robert W Shafer, Walid Heneine |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2007-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC1919426?pdf=render |
Similar Items
-
Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy.
by: Jeffrey A Johnson, et al.
Published: (2008-07-01) -
Epitope mapping of the protease resistant products of RT-QuIC does not allow the discrimination of sCJD subtypes.
by: Gabriele Piconi, et al.
Published: (2019-01-01) -
Drug resistance emergence in macaques administered cabotegravir long-acting for pre-exposure prophylaxis during acute SHIV infection
by: Jessica Radzio-Basu, et al.
Published: (2019-05-01) -
Development of real-time PCR assay allowed describing the first clinical Klebsiella pneumoniae isolate harboring plasmid-mediated colistin resistance mcr-8 gene in Algeria
by: Larbi Zakaria Nabti, et al.
Published: (2020-03-01) -
Highly-sensitive allele-specific PCR testing identifies a greater prevalence of transmitted HIV drug resistance in Japan.
by: Masako Nishizawa, et al.
Published: (2013-01-01)